Fred E Cohen Insider Trading $NTLA Intellia Therapeutics, Inc.
Get free email notifications about insider trading for Fred E Cohen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Fred E Cohen. Fred E Cohen is Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in GENOMIC HEALTH INC ($GHDX) and Director in FIVE PRIME THERAPEUTICS INC ($FPRX) and Director in CareDx, Inc. ($CDNA) and Director in VERACYTE, INC. ($VCYT) and Director in TANDEM DIABETES CARE INC ($TNDM) and Director in Roka BioScience, Inc. ($ROKA) and Director in Progyny, Inc. ($PGNY) and Director in Intellia Therapeutics, Inc. ($NTLA) and Director in UroGen Pharma Ltd. ($URGN).
Fred E Cohen in Intellia Therapeutics, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Fred E Cohen: Director
Holdings: 30,000 shares
Current Value: $399,000
Latest Transaction: Jan 22 2021
$NTLA Market Capitalization: $471.17M
$NTLA Previous Close: $13.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Fred E Cohen in Intellia Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BCRX, CDNA, FPRX, GHDX, NTLA, PGNY, ROKA, TNDM, URGN, VCYT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 22 2021 | NTLA | Intellia Therapeut ... | Cohen Fred E | Director | Option Exercise | M | 13.78 | 20,000 | 275,600 | 18,000 | |
| Jan 22 2021 | NTLA | Intellia Therapeut ... | Cohen Fred E | Director | Buy | M | 13.78 | 20,000 | 275,600 | 30,000 | 10 K to 30 K (+200.00 %) |
| Jun 19 2020 | NTLA | Intellia Therapeut ... | Cohen Fred E | Director | Option Exercise | A | 20.72 | 19,000 | 393,680 | 19,000 | |
| May 22 2019 | NTLA | Intellia Therapeut ... | Cohen Fred E | Director | Option Exercise | A | 15.78 | 19,000 | 299,820 | 19,000 | |
| Mar 05 2019 | NTLA | Intellia Therapeut ... | Cohen Fred E | Director | Grant | A | 16.89 | 10,000 | 168,936 | 10,000 | 0 to 10 K |
| Mar 05 2019 | NTLA | Intellia Therapeut ... | Cohen Fred E | Director | Grant | A | 16.89 | 10,000 | 168,936 | 10,000 | 0 to 10 K |
| Jan 24 2019 | NTLA | Intellia Therapeut ... | Cohen Fred E | Director | Option Exercise | A | 13.78 | 38,000 | 523,640 | 38,000 |
Page: 1